This company has been marked as potentially delisted and may not be actively trading. Conformis (CFMS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CFMS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Conformis (NASDAQ: CFMS)May 3, 2024 | fool.comScaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis AcquisitionJanuary 16, 2024 | finance.yahoo.comCFM Investment JSC CFMDecember 12, 2023 | morningstar.comMComputer Forms (Malaysia) Bhd (CFMS)October 10, 2023 | investing.comStruggling medical device firm Conformis acquired by Duke spinoutSeptember 6, 2023 | bizjournals.comDurham medtech completes acquisition of public companySeptember 5, 2023 | bizjournals.comConformis (Nasdaq:CFMS) HeadlineTrading was temporarily halted for "CFMS" at 07:09 PM with a stated reason of "News pending."...September 4, 2023 | marketbeat.comConformis (Nasdaq:CFMS) HeadlineTrading was temporarily halted for "CFMS" at 07:08 PM with a stated reason of "News pending."...September 1, 2023 | marketbeat.comIndependent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3dAugust 23, 2023 | finance.yahoo.comConformis, Inc.: Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote "FOR" the Pending Merger with restor3dAugust 22, 2023 | finanznachrichten.deIndependent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3dAugust 21, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, EQRX, CFMSAugust 10, 2023 | markets.businessinsider.comThere's No Escaping Conformis, Inc.'s (NASDAQ:CFMS) Muted Revenues Despite A 86% Share Price RiseJuly 20, 2023 | finance.yahoo.comDurham medtech to buy $58M public companyJune 26, 2023 | bizjournals.comSmall medtech startup from Durham to buy $58M public company in cash dealJune 26, 2023 | bizjournals.comConformis Stock (NASDAQ:CFMS), Insider Trading ActivityJune 24, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3dJune 23, 2023 | benzinga.comCFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to ShareholdersJune 23, 2023 | benzinga.comConformis stock nearly doubles on acquisition newsJune 23, 2023 | bizjournals.comConformis, Inc.: Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in CashJune 23, 2023 | finanznachrichten.deRestor3d To Acquire Conformis For $2.27/shr In CashJune 23, 2023 | nasdaq.comWhy Conformis Stock Is Shooting Higher TodayJune 23, 2023 | benzinga.comConformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in CashJune 22, 2023 | finance.yahoo.comConformis, Inc.: Conformis Reports First Quarter 2023 Financial ResultsMay 10, 2023 | finanznachrichten.deConforMIS beats Q1 top and bottom line estimates; initiates Q2 outlookMay 10, 2023 | msn.comConformis Reports First Quarter 2023 Financial ResultsMay 10, 2023 | yahoo.comConformis, Inc. (NASDAQ:CFMS) Q1 2023 Earnings Call TranscriptMay 10, 2023 | finance.yahoo.comConformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023April 13, 2023 | finance.yahoo.comConformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement ProceduresMarch 21, 2023 | finance.yahoo.comConformis, Inc. (NASDAQ:CFMS) Q4 2022 Earnings Call TranscriptMarch 7, 2023 | insidermonkey.comConforMIS (CFMS) Moves to Buy: Rationale Behind the UpgradeMarch 6, 2023 | finance.yahoo.comConformis Full Year 2022 Earnings: Beats ExpectationsMarch 4, 2023 | finance.yahoo.comConformis, Inc. Reports Fourth Quarter and Year End 2022 Financial ResultsMarch 1, 2023 | finance.yahoo.comConformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent LitigationFebruary 15, 2023 | finance.yahoo.comConformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022February 10, 2023 | finance.yahoo.comConformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022January 23, 2023 | finance.yahoo.comConformis, Inc. (CFMS) Stock Historical Prices & Data - Yahoo FinanceJanuary 4, 2023 | finance.yahoo.comConformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price RuleNovember 30, 2022 | finance.yahoo.comConformis Announces First Procedure Performed Using New Actera™ Hip SystemNovember 29, 2022 | finance.yahoo.comConformis Announces Full Commercial Launch of Imprint™November 17, 2022 | finance.yahoo.comConformis, Inc. Announces Settlement of Medacta Patent LitigationNovember 14, 2022 | finance.yahoo.comConformis, Inc.'s (NASDAQ:CFMS) 48% loss last week hit both individual investors who own 52% as well as institutionsNovember 11, 2022 | finance.yahoo.comConformis, Inc. Effects 1-for-25 Reverse Stock SplitNovember 9, 2022 | finance.yahoo.comConformis Reports Third Quarter 2022 Financial ResultsNovember 2, 2022 | finance.yahoo.comConformis, Inc. to Announce Financial Results for Its Third Quarter 2022 - GlobeNewswireOctober 5, 2022 | globenewswire.comConformis, Inc. to Announce Financial Results for Its Third Quarter 2022October 5, 2022 | finance.yahoo.comCFMS.O - ConforMIS Inc | Stock Price & Latest News | ReutersOctober 2, 2022 | reuters.comAfter-Hours Movers: Starbucks Gains On Outlook, Flowserve Falls...September 14, 2022 | au.investing.comPre-Open Movers: Tech Stocks Lift After Drubbing, Block Falls on DowngradeSeptember 14, 2022 | investing.comConformis (NASDAQ:CFMS), BRP (NASDAQ:DOOO) – BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday - BenzingaSeptember 14, 2022 | benzinga.com Get Conformis News Delivered to You Automatically Sign up to receive the latest news and ratings for CFMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CFMS Media Mentions By Week CFMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CFMS News Sentiment▼0.000.99▲Average Medical News Sentiment CFMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CFMS Articles This Week▼00▲CFMS Articles Average Week Get the Latest News and Ratings for CFMS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Conformis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ainos News Today Bone Biologics News Today Heart Test Laboratories News Today Inspira Technologies Oxy B.H.N. News Today Spectral AI News Today TriSalus Life Sciences News Today Nutriband News Today VolitionRx News Today Invivyd News Today Inovio Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CFMS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conformis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conformis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access